JP2024063214A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024063214A5 JP2024063214A5 JP2024034717A JP2024034717A JP2024063214A5 JP 2024063214 A5 JP2024063214 A5 JP 2024063214A5 JP 2024034717 A JP2024034717 A JP 2024034717A JP 2024034717 A JP2024034717 A JP 2024034717A JP 2024063214 A5 JP2024063214 A5 JP 2024063214A5
- Authority
- JP
- Japan
- Prior art keywords
- invention described
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024034717A JP2024063214A (ja) | 2018-11-27 | 2024-03-07 | 骨髄増殖性障害を治療する方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2018/062534 WO2020112086A1 (en) | 2018-11-27 | 2018-11-27 | Methods of treating myeloproliferative disorders |
| JP2021530108A JP7453230B2 (ja) | 2018-11-27 | 2018-11-27 | 骨髄増殖性障害を治療する方法 |
| JP2024034717A JP2024063214A (ja) | 2018-11-27 | 2024-03-07 | 骨髄増殖性障害を治療する方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021530108A Division JP7453230B2 (ja) | 2018-11-27 | 2018-11-27 | 骨髄増殖性障害を治療する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024063214A JP2024063214A (ja) | 2024-05-10 |
| JP2024063214A5 true JP2024063214A5 (cg-RX-API-DMAC7.html) | 2024-08-08 |
Family
ID=64734125
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021530108A Active JP7453230B2 (ja) | 2018-11-27 | 2018-11-27 | 骨髄増殖性障害を治療する方法 |
| JP2024034717A Pending JP2024063214A (ja) | 2018-11-27 | 2024-03-07 | 骨髄増殖性障害を治療する方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021530108A Active JP7453230B2 (ja) | 2018-11-27 | 2018-11-27 | 骨髄増殖性障害を治療する方法 |
Country Status (8)
| Country | Link |
|---|---|
| JP (2) | JP7453230B2 (cg-RX-API-DMAC7.html) |
| KR (2) | KR20250004357A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2018451360B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112021010134A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3120973A1 (cg-RX-API-DMAC7.html) |
| EA (1) | EA202191489A1 (cg-RX-API-DMAC7.html) |
| SG (1) | SG11202105279SA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020112086A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020112939A1 (en) | 2018-11-27 | 2020-06-04 | Constellation Pharmaceuticals, Inc. | Methods of treating myeloproliferative disorders |
| WO2020112086A1 (en) * | 2018-11-27 | 2020-06-04 | Constellation Pharmaceuticals, Inc. | Methods of treating myeloproliferative disorders |
| CA3156007A1 (en) | 2019-09-27 | 2021-04-01 | Disc Medicine, Inc. | METHODS OF TREATING MYELOFIBROSE AND ASSOCIATED CONDITIONS |
| AU2021273014A1 (en) | 2020-05-13 | 2022-11-17 | AbbVie Deutschland GmbH & Co. KG | Anti-hemojuvelin (HJV) antibodies for treating anemia of chronic disease |
| ES3075793T3 (en) | 2020-05-13 | 2026-08-07 | Disc Medicine Inc | Anti-hemojuvelin (hjv) antibodies for treating myelofibrosis |
| AU2021320151A1 (en) * | 2020-08-04 | 2023-02-23 | Constellation Pharmaceuticals, Inc. | 2-((4s)-6-(4-chlorophenyl)-1-methyl-4h-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide for treating thrombocythemia |
| CN122439254A (zh) | 2024-01-18 | 2026-07-21 | 株式会社Lg新能源 | 电极组件、二次电池和电池单元 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR084070A1 (es) * | 2010-12-02 | 2013-04-17 | Constellation Pharmaceuticals Inc | Inhibidores del bromodominio y usos de los mismos |
| CN106687463B (zh) | 2014-06-20 | 2019-04-09 | 星座制药公司 | 一种乙酰胺类化合物的晶型 |
| WO2020112086A1 (en) * | 2018-11-27 | 2020-06-04 | Constellation Pharmaceuticals, Inc. | Methods of treating myeloproliferative disorders |
-
2018
- 2018-11-27 WO PCT/US2018/062534 patent/WO2020112086A1/en not_active Ceased
- 2018-11-27 KR KR1020247040010A patent/KR20250004357A/ko active Pending
- 2018-11-27 AU AU2018451360A patent/AU2018451360B2/en active Active
- 2018-11-27 KR KR1020217019508A patent/KR102738936B1/ko active Active
- 2018-11-27 JP JP2021530108A patent/JP7453230B2/ja active Active
- 2018-11-27 CA CA3120973A patent/CA3120973A1/en active Pending
- 2018-11-27 BR BR112021010134-9A patent/BR112021010134A2/pt not_active Application Discontinuation
- 2018-11-27 SG SG11202105279SA patent/SG11202105279SA/en unknown
- 2018-11-27 EA EA202191489A patent/EA202191489A1/ru unknown
-
2024
- 2024-03-07 JP JP2024034717A patent/JP2024063214A/ja active Pending